---
schema_version: "secwatch.filing_event.v1"
accession: "0001420800-22-000020"
form_type: "8-K"
ticker: "ENOV"
cik: "0001420800"
company_name: "Enovis CORP"
filed_at: "2022-11-02T23:59:59+00:00"
generated_at: "2026-06-22T13:12:30.547181+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Enovis Q3 revenue $384M (+7% organic), adj EPS $0.59 (+34% YoY), guides FY adj EPS $2.20-$2.25

## Summary
- Reconstructive segment revenue $127M (+15% organic); Prevention & Recovery $257M (+4% organic).
- Reported net loss from continuing ops $(66)M ($(1.22)/diluted share); adjusted EPS grew to $0.59.
- Adjusted EBITDA $57M (14.9% of sales); core margins improved 40 bps despite inflation.
- FY 2022 outlook: organic growth ~6.5%, total sales growth ~10%, adj. EBITDA $235-$240M.
- Launched EMPOWR 3D Knee in Europe and two connected bracing products for Motion iQ platform.

## SEC filing metadata
- accession: 0001420800-22-000020
- form_type: 8-K
- ticker: ENOV
- cik: 0001420800
- company_name: Enovis CORP
- filed_at: 2022-11-02T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1420800/000142080022000020/0001420800-22-000020-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1420800/000142080022000020/cfx-20221102.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001420800-22-000020
- JSON: https://secwatch.observer/filing/0001420800-22-000020.json
- Plain text: https://secwatch.observer/filing/0001420800-22-000020.txt

## Key facts
- Earnings Releases
  Enovis CORP reported third quarter 2022 results: revenue $384 million, net income $(66) million, EPS $(1.22) per diluted share.
  - Period: third quarter 2022
  - Revenue: $384 million
  - Net income: $(66) million
  - EPS: $(1.22) per diluted share
  - Result: reported results
  source text: Enovis’ third quarter net sales of $384 million were 7% higher than the prior year third quarter on both reported and organic bases. Enovis Reconstructive segment revenue of $127 million reflected 15% organic growth, and its Prevention and Recovery segment revenue of $257 million reflected 4% organic growth. The Company reported third quarter 2022 net loss from continuing operations of $(66) million, or $(1.22) per diluted share
  evidence_url: https://www.sec.gov/Archives/edgar/data/1420800/000142080022000020/0001420800-22-000020-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.